<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01017835</url>
  </required_header>
  <id_info>
    <org_study_id>503-5139-2</org_study_id>
    <nct_id>NCT01017835</nct_id>
  </id_info>
  <brief_title>Simvastatin in Patients With Isolated Arterial Hypertension</brief_title>
  <acronym>STIPPARE</acronym>
  <official_title>Simvastatin in the Treatment of Isolated Arterial hyPertension and Prevention of cARdiovascular Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Universtity of Lodz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Universtity of Lodz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether combined therapy with simvastatin and
      hypotensive drugs (ACEI or ARB) may decrease the blood pressure. Moreover, we would like to
      assess the influence of isolated hypertension on endothelial injury, and on the development
      of atherosclerosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypertension is one of the most important predictors of cardiovascular diseases (CVD). Due to
      the fact that hypertension frequently coexists with hypercholesterolemia and diabetes which
      increase the risk of CVDs development, it is advisable to use the optimal combined therapy
      (hypotensive + hypolipidemic + hypoglycemic)in this group of patients. Statins are the most
      effective and widely used drugs for the treatment of hypercholesterolemia. According to the
      available experimental and clinical data they may decrease the blood pressure (BP) in
      normotensive and hypertensive patients. However, it is still difficult to determine to what
      degree the reduction of both blood pressure and cardiovascular risk is due to hypotensive or
      hypolipidemic/pleiotropic effects of statins.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>statin treatment, isolated hypertension</arm_group_label>
    <description>treatment with statins, patients with isolated hypertension, with no hyperlipidemia, no diabetes, no smoking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo treatment, isolated hypertension</arm_group_label>
    <description>treatment with placebo, patients with isolated hypertension, with no hyperlipidemia, no diabetes, no smoking</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized in the Department of Nephrology, Hypertension and Family
        Medicine,Clinical Hospital of Medical University of Lodz
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  isolated hypertension (I or II class according to ESH guidelines 2009)

        Exclusion Criteria:

          -  ischemic heart disease, prior percutaneous coronary intervention (PCI), prior coronary
             artery bypass grafting (CABG), heart failure, diabetes, hyperlipidemia, active smokers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maciej Banach, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Departament of Hypertension , Medical University of Lodz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marta Michalska, MSc</last_name>
    <phone>501154853</phone>
    <phone_ext>+48</phone_ext>
    <email>michalska_marta84@wp.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maciej Banach, MD PhD</last_name>
    <phone>604593040</phone>
    <phone_ext>+48</phone_ext>
    <email>maciejbanach@aol.co.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Departament of Nephrology, Hypertension and Family Medicine, Clinical Hospital of Medical University of Lodz</name>
      <address>
        <city>Lodz</city>
        <zip>90-549</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J. Role and significance of statins in the treatment of hypertensive patients. Curr Med Res Opin. 2009 Aug;25(8):1995-2005. doi: 10.1185/03007990903098081. Review.</citation>
    <PMID>19555312</PMID>
  </reference>
  <reference>
    <citation>Rysz J, Aronow WS, Stolarek RS, Hannam S, Mikhailidis DP, Banach M. Nephroprotective and clinical potential of statins in dialyzed patients. Expert Opin Ther Targets. 2009 May;13(5):541-50. doi: 10.1517/14728220902882130 .</citation>
    <PMID>19368496</PMID>
  </reference>
  <reference>
    <citation>Szadkowska I, Stanczyk A, Aronow WS, Kowalski J, Pawlicki L, Ahmed A, Banach M. Statin therapy in the elderly: a review. Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):114-8. doi: 10.1016/j.archger.2008.12.012. Epub 2009 Feb 13. Review.</citation>
    <PMID>19217673</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2009</study_first_submitted>
  <study_first_submitted_qc>November 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2009</study_first_posted>
  <last_update_submitted>November 20, 2009</last_update_submitted>
  <last_update_submitted_qc>November 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2009</last_update_posted>
  <responsible_party>
    <name_title>Maciej Banach</name_title>
    <organization>Departament of Hypertension</organization>
  </responsible_party>
  <keyword>statins</keyword>
  <keyword>isolated hypertension</keyword>
  <keyword>atherosclerosis</keyword>
  <keyword>lipid profile</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

